Azad Bonni, Washington University School of Medicine (IMAGE)

WashU Medicine

Azad Bonni, Washington University School of Medicine

Caption

Washington University School of Medicine in St. Louis researcher Azad Bonni, M.D., Ph.D., has identified a potential target for treatments for people who have a mild version of the mutation that causes fragile X syndrome.

Credit

Robert Boston

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.